| Identification | Back Directory | [Name]
1-Stearoyl-d35-2-hydroxy-sn-glycero-3-PC | [CAS]
327178-92-7 | [Synonyms]
1-Stearoyl-d35-2-hydroxy-sn-glycero-3-PC | [Molecular Formula]
C26H54NO7P | [MOL File]
327178-92-7.mol | [Molecular Weight]
523.69 |
| Hazard Information | Back Directory | [Uses]
1-Stearoyl-sn-glycero-3-phosphocholine-d35 is deuterium labeled 1-Stearoyl-sn-glycero-3-phosphocholine (HY-125771). 1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells[1]. | [Biological Activity]
1-Stearoyl-d35-2-hydroxy-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-stearoyl-2-hydroxy-sn-glycero-3-PC by GC- or LC-MS. 1-Stearoyl-2-hydroxy-sn-glycero-3-PC is a saturated lysophosphatidylcholine. It increases IL-1β production in isolated human blood monocytes when used at a concentration of 12.5 μM.1 Plasma levels of 1-stearoyl-2-hydroxy-sn-glycero-3-PC are decreased in patients with lung cancer.2 | [IC 50]
HDAC3; p-STAT3 | [References]
1.Liu-Wu, Y., Hurt-Camejo, E., and Wiklund, O.Lysophosphatidylcholine induces the production of IL-1β by human monocytesAtherosclerosis137(2)351-357(1998)
2.Dong, J., Xiaoming, C., Zhao, L., et al.Lysophosphatidylcholine profiling of plasma: Discrimination of isomers and discovery of lung cancer biomarkersMetabolomics6(4)478-488(2010)
|
|
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Website: |
www.enzo.com |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|